These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 88025)

  • 1. [Behavior of alpha 2-macroglobulin and alpha 1-antitrypsin in mature diabetics].
    Di Cesare E; Quartarone M; Cucinotta D; Coglitore G; Squadrito G
    Minerva Med; 1979 May; 70(22):1601-3. PubMed ID: 88025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors of coagulation and fibrinolysis in diabetics].
    Tóthová E; Mechír J; Mudronová B; Petrásová D
    Vnitr Lek; 1988 Jun; 34(6):558-63. PubMed ID: 2457985
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of antithrombin III, alpha2-macroglobulin, alpha1-antitrypsin, C1-inhibitor and alpha2-plasmin inhibitor in arteriosclerotic diseases and diabetes mellitus (author's transl)].
    Matsuda T
    Rinsho Ketsueki; 1978 Jul; 19(7):947-54. PubMed ID: 81330
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood levels of alpha 1-antitrypsin and alpha 2-macroglobulin in children with diabetes mellitus].
    Symonides-Lawecka A; Gutkowska J
    Pediatr Pol; 1984 Sep; 59(9):725-30. PubMed ID: 6083539
    [No Abstract]   [Full Text] [Related]  

  • 5. The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy.
    Christe M; Gattlen P; Fritschi J; Lämmle B; Berger W; Marbet GA; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):221-3. PubMed ID: 6085193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha2-macroglobulin in diabetic disease and in its microangiopathic complications].
    Volpi A; Piaserico PL
    Minerva Med; 1983 Oct; 74(39):2287-9. PubMed ID: 6197682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The measurement of proteins with major involvement in the immunological process in a group of 100 elderly patients].
    Căruceru M; Strat E; Creţeanu G
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):763-6. PubMed ID: 2484008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of alpha 1-antitrypsin and alpha 2-macroglobulin in hepatic cirrhosis].
    Amiguet JA; Bueno J; Barrao F; Giménez A; Liso P
    Rev Esp Enferm Apar Dig; 1985 Dec; 68(6):506-10. PubMed ID: 2419949
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dynamics of alpha1-antitrypsin and alpha2-macroglobulin in patients with acute and chronic pneumonia].
    Komar SI; Korobeĭnikova EN
    Vopr Med Khim; 1987; 33(4):46-9. PubMed ID: 2444032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble fibrin complexes and fibrinogen heterogeneity in diabetes mellitus.
    Tsianos EB; Stathakis NE
    Thromb Haemost; 1980 Dec; 44(3):130-4. PubMed ID: 6162208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-2-antichymotrypsin in patients with lung carcinoma.
    Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kiluk S; Gluszczak M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):817-23. PubMed ID: 2467852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activity of selected proteinase inhibitors in patients with disorders of lipid metabolism].
    Kopieczna-Grzebieniak E; Drózdz M; Grabowska-Bochenek R; Piekarski M
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):12-4. PubMed ID: 1384011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of analysis of alpha 2-macroglobulin in the diagnosis of diabetic diseases].
    Hanabusa T; Hirayama J; Nanjo K
    Nihon Rinsho; 1990 Dec; 48 Suppl():345-8. PubMed ID: 1707992
    [No Abstract]   [Full Text] [Related]  

  • 15. [Alpha 1-antitrypsin, alpha 2-macroglobulin and reactive protein C in gastric cancer].
    Dumitraşcu D; Radu D; Stanciu L; Ioniţă A; Petcovici M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(1):57-61. PubMed ID: 2479968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of some indices of fibrinolysis (fibrinogen, FDP, plasminogen) in mature diabetics].
    Di Cesare E; Quartarone M; Cucinotta D; Coppolino E; Squadrito G
    Minerva Med; 1979 May; 70(22):1597-9. PubMed ID: 450299
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dynamics of proteolysis inhibitor concentration (alpha 1-antitrypsin and alpha 2-macroglobulins) and proteolytic activity in the blood of burn patients].
    Krimshteĭn TA; Chesnokova NB
    Patol Fiziol Eksp Ter; 1980; (2):27-30. PubMed ID: 6156435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Alpha 2-macroglobulin in the blood of patients with diabetes mellitus].
    Turecký L; Kupcová V; Szántová M
    Bratisl Lek Listy; 1999 Jan; 100(1):25-7. PubMed ID: 10492994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of changes in main serum proteinase inhibitors (alpha 1-antitrypsin and alpha 2-macroglobulin) in patients with pulmonary tuberculosis].
    Kaminskaia GO; Zhukova NL; Chukanov VI
    Probl Tuberk; 1983 Dec; (12):50-6. PubMed ID: 6198643
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in alpha 1-antitrypsin (AAT) and alpha 2-macroglobulin serum concentrations during treatment with oral estro-progestogens.
    Paternoster D; Maggino T; Valente S; Pengo V; Ongaro G
    Quad Sclavo Diagn; 1982 Jun; 18(2):132-9. PubMed ID: 6188185
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.